Genetic factors, environmental factors, and gene–environment interactions have been found
to modify PD risk, age at onset (AAO), and disease progression. The objective of this study …

Objectives The effect of environmental and lifestyle factors on patients with LRRK2 (leucine‐rich
repeat kinase 2) p.Gly2019Ser (LRRK2 + /PD + ) compared to idiopathic PD (iPD) has …

Parkinson’s disease (PD) is a progressive neurodegenerative disorder. Genetic modifiers,
environmental factors and gene–environment interactions have been found to modify PD risk …

While many genetic causes of movement disorders have been identified, modifiers of
disease expression are largely unknown. X-linked dystonia-parkinsonism (XDP) is a …

Objective Our study investigated the presence of regional differences in hexanucleotide
repeat number in postmortem brain tissues of 2 patients with X-linked dystonia-parkinsonism (…

Biallelic mutations in PINK1/PRKN cause recessive Parkinson’s disease. Given the established
role of PINK1/Parkin in regulating mitochondrial dynamics, we explored mitochondrial …

Objective: To establish a workflow for mitochondrial DNA (mtDNA) CpG methylation using
Nanopore whole-genome sequencing and perform first pilot experiments on affected Parkin …

Background: Sequencing quality has improved over the last decade for long-reads, allowing
for more accurate detection of somatic low-frequency variants. In this study, we used …

Background: X-linked dystonia-parkinsonism (XDP) is an adult-onset neurodegenerative
disorder characterized by progressive dystonia and parkinsonism. It is caused by a SINE-VNTR…

Different pathogenic variants in the DNA polymerase-gamma2 (POLG2) gene cause a rare,
clinically heterogeneous mitochondrial disease. We detected a novel POLG2 variant (c.1270 …